NKGN

NKGen Biotech (NKGN)

NKGen Biotech Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NKGN

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/03/05	03 : 00	GlobeNewswire Inc.	NKGen Biotech, Inc. to Transition from the Nasdaq Global Market to OTC Markets; Reverse Stock Split will not be Implemented	NASDAQ:NKGN	NKGen Biotech Inc
2025/02/13	06 : 10	AllPennyStocks.com	FDA Fast Track Designation Sends Biotech Soaring Mid-Week	NASDAQ:NKGN	NKGen Biotech Inc
2024/08/30	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NKGN	NKGen Biotech Inc
2024/08/23	06 : 22	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:NKGN	NKGen Biotech Inc
2024/08/23	05 : 42	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NKGN	NKGen Biotech Inc
2024/08/22	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NKGN	NKGen Biotech Inc
2024/08/10	06 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NKGN	NKGen Biotech Inc
2024/07/30	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NKGN	NKGen Biotech Inc
2024/02/23	06 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NKGN	NKGen Biotech Inc
2024/02/15	10 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NKGN	NKGen Biotech Inc
2024/02/15	10 : 16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NKGN	NKGen Biotech Inc
2024/02/15	10 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NKGN	NKGen Biotech Inc
2024/02/15	10 : 11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NKGN	NKGen Biotech Inc
2024/02/15	03 : 05	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:NKGN	NKGen Biotech Inc
2024/01/22	20 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NKGN	NKGen Biotech Inc
2024/01/09	07 : 19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NKGN	NKGen Biotech Inc
2023/12/29	06 : 14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NKGN	NKGen Biotech Inc
2023/12/28	06 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NKGN	NKGen Biotech Inc
2023/12/28	06 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NKGN	NKGen Biotech Inc
2023/12/20	03 : 41	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:NKGN	NKGen Biotech Inc
2023/11/15	06 : 39	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NKGN	NKGen Biotech Inc
2023/10/24	23 : 56	Dow Jones News	NKGen Biotech Shares Rise 8% After FDA Clears IND Application for SNK01	NASDAQ:NKGN	NKGen Biotech Inc
2023/10/24	21 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NKGN	NKGen Biotech Inc